Daewoong Inks Autotelic Deal To Help International Expansion
This article was originally published in PharmAsia News
Executive Summary
After a fairly smooth launch for its combination drug Olostar in South Korea last year, Daewoong is now taking the product into global markets as part of its international expansion strategy.